fatigue

[키워드] 1:1 accompany Admission age alcohol allocation concealment ALT/AST Arm assigned Beta block-randomization Blood body temperature Care clinical Clinical improvement clinical trial comparator Confirmed control group COVID COVID-19 COVID-2019 CT scan death discharge disease dissemination drug duration of hospitalization Effect Effectiveness element eligibility criteria exclusion criteria fatigue group headache Health High dose High-dose hospital hospital discharge Hospitalization improvement incidence include Infection information Interaction interferon beta Interferon beta-1a Interferon-β 1a intervention group Intubated Invasive mechanical ventilation investigator Kaletra Laboratory results lactating women Last less limit Loghman Hakim Hospital Lopinavir/ritonavir low dose low-dose masking mechanical ventilation Medical Sciences moderate Mortality nasal Non-invasive number objective open label Open-label outcome oxygen saturation oxygen support package parallel group participant Patient pregnant Primary outcome primary outcome measure professional protocol R software Radiation randomised randomization randomization sequence Randomized Randomized controlled trial Randomly receive Recigen recruitment refusal regimen Registered Research respiratory rate Ritonavir RT-PCR RT-PCR test Sample size SARS-CoV-2 sealed secondary secondary outcome seven-category ordinal scale severe disease Shortness of breath single center standard care status Study protocol Symptom the patient therapeutic time treated treatment groups Trial two groups university version 3.6.1 website World Health Organization
[DOI] 10.1186/s13063-020-04812-2 PMC 바로가기 [Article Type] Letter